Mail

UK markets closed

FTSE 100
8,146.86
-16.81(-0.21%)
FTSE 250
20,120.36
-75.59(-0.37%)
AIM
776.04
-4.39(-0.56%)
GBP/EUR
1.1845
-0.0034(-0.29%)
GBP/USD
1.2686
-0.0074(-0.58%)
Bitcoin GBP
52,160.73
-100.06(-0.19%)

How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

Sailong Pharmaceutical Group Co.,Ltd. (002898.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

9.14

-0.02

(-0.22%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	1.61B
Enterprise value	1.68B
Trailing P/E	202.21
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	5.35
Price/book (mrq)	2.99
Enterprise value/revenue	5.58
Enterprise value/EBITDA	60.44

Trading information

Stock price history

Beta (5Y monthly)	0.10
52-week change ³	-15.29%
S&P500 52-week change ³	23.76%
52-week high ³	20.02
52-week low ³	7.70
50-day moving average ³	10.00
200-day moving average ³	12.04

Share statistics

Avg vol (3-month) ³	5.35M
Avg vol (10-day) ³	2.44M
Shares outstanding ⁵	176M
Implied shares outstanding ⁶	176.4M
Float ⁸	60.15M
% held by insiders ¹	66.09%
% held by institutions ¹	0.57%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.02
Trailing annual dividend yield ³	0.22%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	16 Jul 2020
Last split factor ²	1.1:1
Last split date ³	16 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	2.65%
Operating margin (ttm)	3.64%

Management effectiveness

Return on assets (ttm)	0.96%
Return on equity (ttm)	1.49%

Income statement

Revenue (ttm)	300.68M
Revenue per share (ttm)	1.71
Quarterly revenue growth (yoy)	-12.50%
Gross profit (ttm)	N/A
EBITDA	44.89M
Net income avi to common (ttm)	7.96M
Diluted EPS (ttm)	0.04
Quarterly earnings growth (yoy)	-49.20%

Balance sheet

Total cash (mrq)	58.69M
Total cash per share (mrq)	0.33
Total debt (mrq)	127.25M
Total debt/equity (mrq)	23.67%
Current ratio (mrq)	1.15
Book value per share (mrq)	3.05

Cash flow statement

Operating cash flow (ttm)	23.82M
Levered free cash flow (ttm)	-34.74M